Although, in a more recent study that evaluated ACE and ACE2 protein expression and enzyme activity in the frontal and temporal cortex in early AD stages, authors report that both ACE and ACE2 protein level are unchanged and that only ACE enzyme activity was elevated (MacLachlan et al., 2022). The gene discussed is ACE2; the disease is Alzheimer disease.